Return to Publications
November 2017
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Top Docs

Rutgers Cancer Institute of New Jersey Physicians Named 'Jersey Choice'

Several physicians at Rutgers Cancer Institute of New Jersey were selected as a 'Jersey Choice Top Doctor' by New Jersey Monthly magazine. As chief of their respective divisions and sections they provide leadership and represent the outstanding patient care provided. An independent research firm was commissioned by the magazine to conduct the 2017 survey. Thousands of New Jersey-based doctors were asked to give physician recommendations, which resulted in more than 3,300 individual nominations. A select group of physicians were named to the final list following a professional review by a panel of doctors.


$2.4M Grant Aids Exploration of Social Media to Reduce Indoor Tanning Behavior

A $2.4 million grant from the National Cancer Institute awarded to Rutgers Cancer Institute of New Jersey behavioral scientist Jerod L. Stapleton, PhD, assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, will support the development and testing of a novel behavioral intervention delivered through the social media site Facebook. The aim is to reduce high-risk indoor tanning behaviors among young women.


Elucidating the Role of Circulating Nutrients that Fuel Tumor Growth

Tumors acquire nutrition necessary for growth and survival from the body of the patient in which they reside. Although these nutrients are predominantly provided by the circulating blood supply, the knowledge of how they are used by tumors is incomplete. Identifying tumor nutrients and how they are used may reveal novel approaches to cancer therapy. Research from investigators at Rutgers Cancer Institute of New Jersey and Princeton University, published in the October 18 edition of Nature, finds that circulating lactate rather than glucose is the prominent metabolic fuel source for tumors and most normal tissues.


Learning More about Pancreatic Cancer

According to the Surveillance, Epidemiology, and End Results (SEER) Program database, there will be an estimated 53,670 new pancreatic cancer cases this year in the U.S. While many patients still die from this disease, this proportion of patients has been stable for the last ten years, suggesting progress is being made in battling this challenging type of cancer. Kristen Spencer, DO, MPH, a medical oncologist in the Gastrointestinal/Hepatobiliary Program at Rutgers Cancer Institute and an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, shares some insight during this Pancreatic Cancer Awareness Month.


New Insight on Nuclear Organization of DNA and its Impact on Patterns of Mutations in Cancer

Research by Rutgers Cancer Institute investigators and others shows that the architecture of a cell's nucleus influences the type and frequency of mutations in cancer genomes beyond the effects already captured by DNA packaging and ordering. Rutgers Cancer Institute resident research member Subhajyoti De, PhD, who is an assistant professor of pathology at Rutgers Robert Wood Johnson Medical School, is the senior author of the work published in the October 2, online issue of Nature Structural & Molecular Biology.